Clemastine Treatment in Individuals With Williams Syndrome
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This study explores the neurobiological etiology of Williams syndrome and potential
therapeutic targets for associated social, motor, and cognitive abnormalities. The main
translational objective will be to test the effectiveness of Clemasntine on neurocognitive
and other associated abnormalities in individuals with Williams syndrome.